{"url_path":"/sec/cik-0001012477/8-k/2026-02-12/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-02-12","source_url":"https://www.sec.gov/Archives/edgar/data/1012477/0001104659-26-013880-index.html","accession_number":"0001104659-26-013880","cik":"0001012477","ticker":null,"issuer_name":"AVADEL PHARMACEUTICALS PLC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1012477/0001104659-26-013880-index.html","primary_entity_key":"0001012477","primary_entity_name":"AVADEL PHARMACEUTICALS PLC"},"word_count":82,"has_tables":true,"body_markdown":"**Item 5.03**\n**Amendments to Articles of Incorporation or Bylaws; Change of Fiscal Year.**\n\n \n\nPursuant to the Transaction Agreement and following the approval of\nthe Avadel Shareholders at the EGM convened in connection with the Scheme, effective as of the Effective Time, the Memorandum and Articles\nof Association of the Company were amended. A copy of the amended Memorandum and Articles of Association of the Company is filed as Exhibit 3.1\nto this Current Report on Form 8-K and incorporated herein by reference."}